HOME >> MEDICINE >> NEWS
HHS announces contracts for developing a new anthrax vaccine

HHS Secretary Tommy G. Thompson today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded two companies contracts designed to spur development of a new anthrax vaccine. The two contracts total $22.5 million through Fiscal Year 2003.

"There is an urgent need to devise more effective measures to protect U.S. citizens from the harmful effects of anthrax spores used as instruments of terror," said Secretary Thompson. "These awards represent the first step toward our goal of securing an initial 25 million doses of an improved anthrax vaccine for our emergency stockpile."

"Vaccines are the best method of protecting the public against infectious diseases," said NIAID Director Anthony S. Fauci, M.D. "At NIAID, one of our top priorities is to work with industry to create new and improved vaccines against possible agents of bioterrorism. These vaccines must be suitable for civilian populations of varying ages and health status. In addition, the vaccines must be safe, easy to administer, and capable of inducing an immediate protective immune response."

The currently licensed anthrax vaccine, administered almost exclusively to military personnel, must be given in six doses over 18 months. The new vaccine will be required to provide immunity to inhalation anthrax in three or fewer doses, which is expected to reduce the administration time. It is hoped that a quicker administration time and other technological improvements would allow the vaccine to protect individuals from anthrax spores even if the vaccine was given shortly after exposure.

The companies awarded contracts today are Avecia, of Manchester, United Kingdom, and VaxGen Inc., of Brisbane, California.

Under the terms of the contracts, the companies will base their vaccine candidates on a promising vaccine concept. The vaccine will contain the protective antigen of the anthrax bacterium, which will be produced with recombinant DNA techno
'"/>

Contact: Jeff Minerd
jminerd@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
3-Oct-2002


Page: 1 2

Related medicine news :

1. The Gerontological Society of America announces Hartford Fellowship recipients
2. TB Alliance announces new drug discovery program with GlaxoSmithKline
3. ASGE announces grant recipients in annual research awards program
4. Novartis announces collaboration with Bayer for EMSELEX
5. American College of Chest Physicians announces new Critical Care Institute
6. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
7. Department of Energy announces new agreement with USC, national labs and private company
8. ACP announces international medical fellowship
9. St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study
10. St. Jude Medical announces PAVE and DINAMIT clinical trial results
11. National Inventors Hall of Fame announces 2004 class of inventors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... that offers insurance and financial preparation services, is providing an update on a ... organization. , Rock City Rescue is a locally recognized nonprofit that provides shelter ...
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology:
Cached News: